Background: How to address the counseling of lifetime risk of developing Parkinson's disease in patients with Gaucher disease and their family members carrying a single variant of the GBA1 gene is not yet clearly defined. In addition, there is no set way of managing Gaucher disease patients, taking into account the possibility that they may show features of Parkinson's disease. Methods: Starting from an overview on what has recently changed in our knowledge on this issue and grouping the experiences of healthcare providers of Gaucher disease patients, we outline a path of counseling and management of Parkinson's disease risk in Gaucher disease patients and their relatives. Conclusion: The approach proposed here will help healthcare providers to communicate Parkinson's disease risk to their patients and will reduce the possibility of patients receiving inaccurate information from inadequate sources. Furthermore, this resource will help to empower healthcare providers to identify early signs and/or symptoms of Parkinson's disease and decide when to refer these patients to the neurologist for appropriate specific therapy and follow-up.
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives? / Di Rocco, M.; Di Fonzo, A.; Barbato, A.; Cappellini, M. D.; Carubbi, F.; Giona, F.; Giuffrida, G.; Linari, S.; Pession, A.; Quarta, A.; Scarpa, M.; Spada, M.; Strisciuglio, P.; Andria, G.. - In: ORPHANET JOURNAL OF RARE DISEASES. - ISSN 1750-1172. - 15:1(2020), pp. 262-267. [10.1186/s13023-020-01529-y]
Parkinson's disease in Gaucher disease patients: What's changing in the counseling and management of patients and their relatives?
Carubbi F.Writing – Original Draft Preparation
;
2020
Abstract
Background: How to address the counseling of lifetime risk of developing Parkinson's disease in patients with Gaucher disease and their family members carrying a single variant of the GBA1 gene is not yet clearly defined. In addition, there is no set way of managing Gaucher disease patients, taking into account the possibility that they may show features of Parkinson's disease. Methods: Starting from an overview on what has recently changed in our knowledge on this issue and grouping the experiences of healthcare providers of Gaucher disease patients, we outline a path of counseling and management of Parkinson's disease risk in Gaucher disease patients and their relatives. Conclusion: The approach proposed here will help healthcare providers to communicate Parkinson's disease risk to their patients and will reduce the possibility of patients receiving inaccurate information from inadequate sources. Furthermore, this resource will help to empower healthcare providers to identify early signs and/or symptoms of Parkinson's disease and decide when to refer these patients to the neurologist for appropriate specific therapy and follow-up.File | Dimensione | Formato | |
---|---|---|---|
Di Fonzo parkinson 2020 s13023-020-01529-y.pdf
Open access
Descrizione: articolo originale
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
736.34 kB
Formato
Adobe PDF
|
736.34 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris